Chia Tai Tianqing Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChia Tai Tianqing Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fosaprepitant dimeglumine	Fosaprepitant dimeglumine	2021-03-03		—
Fulvestrant	Fulvestrant	2020-02-07	2034	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

male breast neoplasms

,

,

cutaneous malignant melanoma

,

abdominal neoplasms

,

retroperitoneal neoplasms

,

renal insufficiency

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

prostatic neoplasms

,

,

inflammatory breast neoplasms

,

,

colorectal neoplasms

,

urethral neoplasms

,

ureteral neoplasms

,

renal cell carcinoma

,

fallopian tube neoplasms

,

head and neck neoplasms

,

,

rhabdomyosarcoma

,

,

pancreatic neoplasms

,

kidney neoplasms

,

pelvic neoplasms

,

colonic neoplasms

,

,

circulating neoplastic cells

,

,

soft tissue neoplasms

,

malignant fibrous histiocytoma

,

pathologic complete response

,

solitary fibrous tumors

,

hemangiopericytoma

,

fibrous tissue neoplasms

,

hemangiosarcoma

,

epithelioid hemangioendothelioma

,

hemangioendothelioma

,

,

uterine cervical neoplasms

,

salivary gland neoplasms

,

castration-resistant prostatic neoplasms

,

uterine neoplasms

,

,

mullerian mixed tumor

,

hepatocellular carcinoma

,

,

triple negative breast neoplasms

,

,

,

,

,

neoplasm metastasis

,

brain neoplasms

,

non-small-cell lung carcinoma

,

transitional cell carcinoma

,

,

urinary bladder neoplasms

,

urologic neoplasms

,

hereditary breast and ovarian cancer syndrome

,

,

,

invasive hydatidiform mole

,

second primary neoplasms

,

meningeal carcinomatosis

,

,

breast neoplasms

,

male breast neoplasms

,

drug-related side effects and adverse reactions

,

neurotoxicity syndromes

,

peripheral nervous system diseases

,

alopecia areata

Eribulin mesylate

,

breast neoplasms

,

pancreatic neoplasms

,

Mycophenolate sodium

sjogren's syndrome

,

,

,

lupus nephritis

,

,

,

disease progression

,

autoimmune diseases

,

,

organ transplantation

,

graft vs host disease

,

intermediate uveitis

,

,

systemic lupus erythematosus

,

pancreas transplantation

,

kidney transplantation

,

liver transplantation

,

heart transplantation

,

chronic kidney failure

,

immunosuppression therapy

,

kidney diseases

,

,

,

graft rejection

,

,

renal insufficiency

,

gastrointestinal diseases

,

,

interstitial lung diseases

,

vascular diseases

,

,

transplantation

,

digestive signs and symptoms

,

chronic renal insufficiency

,

,

renal replacement therapy

,

digestive system diseases

,

primary graft dysfunction

,

cytomegalovirus infections

,

communicable diseases

,

cytomegalovirus

,

,

polyomavirus infections

,

drug interactions

,

,

end stage liver disease

,

lung transplantation

,

sickle cell anemia

,

hematologic neoplasms

,

non-small-cell lung carcinoma

,

,

,

squamous cell carcinoma

,

squamous cell neoplasms

,

migraine disorders

,

prostatic neoplasms

,

,

breast neoplasms

,

ovarian neoplasms

,

pancreatic neoplasms

,

,

ovarian epithelial carcinoma

,

,

psychotic disorders

Mycophenolic acid

sjogren's syndrome

,

,

lupus nephritis

,

,

,

disease progression

,

patient compliance

,

lung transplantation

,

graft vs host disease

,

autoimmune diseases

,

,

,

organ transplantation

,

nephrotic syndrome

,

,

intermediate uveitis

,

,

systemic lupus erythematosus

,

pancreas transplantation

,

kidney transplantation

,

liver transplantation

,

chronic kidney failure

,

immunosuppression therapy

,

heart transplantation

,

kidney diseases

,

renal insufficiency

,

,

,

,

graft rejection

,

,

,

gastrointestinal diseases

,

cytomegalovirus infections

,

communicable diseases

,

interstitial lung diseases

,

polyomavirus infections

,

,

liver cirrhosis

,

vascular diseases

,

transplantation

,

digestive signs and symptoms

,

chronic renal insufficiency

,

,

renal replacement therapy

,

drug-related side effects and adverse reactions

,

digestive system diseases

,

primary graft dysfunction

,

cytomegalovirus

,

cross-sectional studies

,

drug interactions

,

,

wounds and injuries

,

reperfusion injury

,

diabetes mellitus

,

,

end stage liver disease

,

,

myeloid leukemia acute

,

myeloid leukemia

gastrointestinal neoplasms

,

digestive system neoplasms

squamous cell carcinoma

,

colorectal neoplasms

,

stomach neoplasms

,

pancreatic neoplasms

,

esophageal squamous cell carcinoma

,

squamous cell carcinoma of head and neck

,

large b-cell lymphoma diffuse

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

thyroid neoplasms

,

breast neoplasms

,

,

rectal neoplasms

,

b-cell lymphoma

,

pheochromocytoma

,

urologic neoplasms

,

gastrointestinal stromal tumors

,

neuroendocrine tumors

,

small cell lung carcinoma

,

female genital neoplasms

,

,

uterine cervical neoplasms

,

neoplasms by histologic type

,

triple negative breast neoplasms

,

male breast neoplasms

,

essential tremor

,

head and neck neoplasms

,

,

gastrointestinal diseases

,

digestive system diseases

,

,

,

,

,

esophageal neoplasms

,

neoplasm metastasis

,

neoadjuvant therapy

,

,

,

,

,

,

hepatocellular carcinoma

,

nasopharyngeal carcinoma

,

liver neoplasms

,

nasopharyngeal neoplasms

,

hodgkin disease

,

squamous cell neoplasms

,

,

hypersensitivity

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

small cell carcinoma

,

thyroid diseases

healthy volunteers/patients

,

pharmacokinetics

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

non-alcoholic fatty liver disease

,

,

Efbemalenograstim alfa

non-small-cell lung carcinoma

,

,

febrile neutropenia

,

colorectal neoplasms

,

pancreatic neoplasms

,

ovarian neoplasms

,

uterine cervical neoplasms

,

,

breast neoplasms

,

Aglatimagene besadenovec

,

,

head and neck neoplasms

,

esophageal neoplasms

,

disease progression

,

neuroendocrine carcinoma

,

castration-resistant prostatic neoplasms

,

,

,

large b-cell lymphoma diffuse

,

,

small cell lung carcinoma

,

renal cell carcinoma

,

urogenital neoplasms

,

male genital diseases

,

prostatic diseases

,

abdominal neoplasms

,

male genital neoplasms

,

genital diseases

,

,

myelomonocytic leukemia chronic

,

systemic mastocytosis

,

myelomonocytic leukemia juvenile

,

hypereosinophilic syndrome

,

,

dermatofibrosarcoma

,

hematologic neoplasms

,

,

b-cell lymphoma

,

neuroendocrine tumors

,

urologic neoplasms

,

kidney neoplasms

,

endometrial neoplasms

,

t-cell lymphoma

,

malignant mesothelioma

,

clear cell adenocarcinoma

,

,

adenomyoepithelioma

,

,

thrombocytopenia

,

,

,

,

,

,

,

,

,

bone resorption

,

,

prostatic neoplasms

,

neoplasm metastasis

,

breast neoplasms

,

,

bone marrow diseases

,

multiple myeloma

,

second primary neoplasms

,

hypersensitivity

,

plasma cell neoplasms

,

,

,

,

myeloid leukemia acute

,

myeloid leukemia

,

,

,

biphenotypic leukemia acute

,

eyelid neoplasms

,

myeloid sarcoma

1

2

3

4

5

6

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use